Magdalena Sternak

Magdalena Sternak

Auto-generated profile, based on publicly available information

Magdalena Sternak

Jagiellonian University, Jagiellonian Centre for Experimental Therapeutics (JCET), Krakow, Poland

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2018 in Breast Cancer Research
Verified
Journal Article
Open access
PDF file
MWMarta Wojewoda
Marta Wojewoda
AKAnna Kieronska-Rudek
Anna Kieronska-Rudek
MAMateusz G. Adamski
Mateusz G. Adamski
BPBartosz Proniewski
Bartosz Proniewski
MSMagdalena Sternak
Magdalena Sternak
SCStefan Chlopicki
Stefan Chlopicki
Mesenchymal transformation of pulmonary endothelial cells contributes to the formation of a metastatic microenvironment, but it is not known whether this precedes or follows early metastasis formation. In the present work, we characterize the development of nitric oxide (NO) deficiency and markers of endothelial–mesenchymal transition (EndMT) in the lung in relation to the progression of 4T1 metastatic breast cancer injected orthotopically in mice. NO production, endothelial nitric oxide synthase (eNOS) phosphorylation status, markers of EndMT in the lung, pulmonary endothelium permeability, and platelet activation/reactivity were analyzed in relation to the progression of 4T1 breast cancer metastasis to the lung, as well as to lung tissue remodeling, 1–5 weeks after 4T1 cancer cell inoculation in Balb/c mice. Phosphorylation of eNOS and NO production in the lungs of 4T1 breast cancer-bearing mice was compromised prior to the development of pulmonary metastasis, and was associated with overexpression of Snail transcription factor in the pulmonary endothelium. These changes developed prior to the mesenchymal phenotypic switch in the lungs evidenced by a decrease in vascular endothelial-cadherin (VE-CAD) and CD31 expression, and the increase in pulmonary endothelial permeability, phenomena which coincided with early pulmonary metastasis. Increased activation of platelets was also detected prior to the early phase of metastasis and persisted to the late phase of metastasis, as evidenced by the higher percentage of unstimulated platelets binding fibrinogen without changes in von Willebrand factor and fibrinogen binding in response to ADP stimulation. Decreased eNOS activity and phosphorylation resulting in a low NO production state featuring pulmonary endothelial dysfunction was an early event in breast cancer pulmonary metastasis, preceding the onset of its phenotypic switch toward a mesenchymal phenotype (EndMT) evidenced by a decrease in VE-CAD and CD31 expression. The latter coincided with development of the first metastatic nodules in the lungs. These findings suggest that early endothelial dysfunction featured by NO deficiency rather than EndMT, might represent a primary regulatory target to prevent early pulmonary metastasis.

7 October 2021 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
TMTasnim Mohaissen
Tasnim Mohaissen
BPBartosz Proniewski
Bartosz Proniewski
MTMarta Targosz-Korecka
Marta Targosz-Korecka
ABAnna Bar
Anna Bar
AKAgnieszka Kij
Agnieszka Kij
SCStefan Chlopicki
Stefan Chlopicki
Endothelial dysfunction (ED) and red blood cell distribution width (RDW) are both prognostic factors in heart failure (HF), but the relationship between them is not clear. In this study, we used a unique mouse model of chronic HF driven by cardiomyocyte-specific overexpression of activated Gαq protein (Tgαq*44 mice) to characterize the relationship between the development of peripheral ED and the occurrence of structural nanomechanical and biochemical changes in red blood cells (RBCs). Systemic ED was detected in vivo in 8-month-old Tgαq*44 mice, as evidenced by impaired acetylcholine-induced vasodilation in the aorta and increased endothelial permeability in the brachiocephalic artery. ED in the aorta was associated with impaired nitric oxide (NO) production in the aorta and diminished systemic NO bioavailability. ED in the aorta was also characterized by increased superoxide and eicosanoid production. In 4- to 6-month-old Tgαq*44 mice, RBC size and membrane composition displayed alterations that did not result in significant changes in their nanomechanical and functional properties. However, 8-month-old Tgαq*44 mice presented greatly accentuated structural and size changes and increased RBC stiffness. In 12-month-old Tgαq*44 mice, the erythropathy was featured by severely altered RBC shape and elasticity, increased RDW, impaired RBC deformability, and increased oxidative stress (gluthatione (GSH)/glutathione disulfide (GSSG) ratio). Moreover, RBCs taken from 12-month-old Tgαq*44 mice, but not from 12-month-old FVB mice, coincubated with aortic rings from FVB mice, induced impaired endothelium-dependent vasodilation and this effect was partially reversed by an arginase inhibitor [2(S)-amino-6-boronohexanoic acid]. In the Tgαq*44 murine model of HF, systemic ED accelerates erythropathy and, conversely, erythropathy may contribute to ED. These results suggest that erythropathy may be regarded as a marker and a mediator of systemic ED in HF. RBC arginase and possibly other RBC-mediated mechanisms may represent novel therapeutic targets for systemic ED in HF.

1 April 2019 in Experimental and Molecular Pathology
Verified
Journal Article
Closed access
AKAnna Kurpinska
Anna Kurpinska
JSJoanna Suraj
Joanna Suraj
EBEmilia Bonar
Emilia Bonar
AZAgnieszka Zakrzewska
Agnieszka Zakrzewska
MSMarta Stojak
Marta Stojak
MWMaria Walczak
Maria Walczak

1 November 2019 in Vascular Pharmacology
Verified
Journal Article
Closed access
ABAnna Bar
Anna Bar
KKKamil Kus
Kamil Kus
AMAngelika Manterys
Angelika Manterys
BPBartosz Proniewski
Bartosz Proniewski
MSMagdalena Sternak
Magdalena Sternak
SCStefan Chlopicki
Stefan Chlopicki

1 January 2019 in Disease Models & Mechanisms
Verified
Journal Article
Open access
PDF file
JSJoanna Suraj
Joanna Suraj
AKAnna Kurpinska
Anna Kurpinska
AZAgnieszka Zakrzewska
Agnieszka Zakrzewska
MSMagdalena Sternak
Magdalena Sternak
MSMarta Stojak
Marta Stojak
SCStefan Chlopicki
Stefan Chlopicki
The endothelium plays an important role in cancer metastasis, but the mechanisms involved are still not clear. In the present work, we characterised the changes in endothelial function at early and late stages of breast cancer progression in an orthotopic model of murine mammary carcinoma (4T1 cells). Endothelial function was analysed based on simultaneous microLC/MS-MRM quantification of 12 endothelium-related biomarkers reflecting glycocalyx disruption [syndecan-1 (SDC-1), endocan (ESM-1)], endothelial inflammation [vascular cell adhesion molecule 1 (VCAM-1), intercellular adhesion molecule 1 (ICAM-1), E-selectin (E-sel)], endothelial permeability [fms-like tyrosine kinase 1 (FLT-1), angiopoietin 2 (Angpt-2)], haemostasis [von Willebrand factor (vWF), tissue plasminogen activator (t-PA), plasminogen activator inhibitor 1 (PAI-1)] and others pathophysiologically linked to endothelial function [e.g. adrenomedullin (ADM), adiponectin (ADN)]. The early phase of metastasis in mouse plasma was associated with glycocalyx disruption (increased SDC-1 and ESM-1), endothelial inflammation (increased sVCAM-1) and increased vascular permeability (Angpt-2). During the late phase of metastasis, additional alterations in haemostasis (increased PAI-1 and vWF), as well as a rise in ADM and substantial fall in ADN concentration were observed. In conclusion, in a murine model of breast cancer metastasis, we identified glycocalyx disruption, endothelial inflammation and increased endothelial permeability as important events in early metastasis, while the late phase of metastasis was additionally characterised by alterations in haemostasis.

Verified
Journal Article
Open access
PDF file
KCKrzysztof Czamara
Krzysztof Czamara
ZMZuzanna Majka
Zuzanna Majka
MSMagdalena Sternak
Magdalena Sternak
MKMateusz Koziol
Mateusz Koziol
RKRenata Kostogrys
Renata Kostogrys
AKAgnieszka Kaczor
Agnieszka Kaczor
Fiber optic Raman spectroscopy and Raman microscopy were used to investigate alterations in the aorta wall and the surrounding perivascular adipose tissue (PVAT) in the murine model of atherosclerosis (Apoe-/-/Ldlr-/- mice). Both abdominal and thoracic parts of the aorta were studied to account for the heterogenic chemical composition of aorta and its localization-dependent response in progression of atherosclerosis. The average Raman spectra obtained for both parts of aorta cross sections revealed that the chemical composition of intima-media layers along aorta remains relatively homogeneous while the lipid content in the adventitia layer markedly increases with decreasing distance to PVAT. Moreover, our results demonstrate that the increase of the lipid to protein ratio in the aorta wall correlates directly with the increased unsaturation level of lipids in PVAT and these changes occur only in the abdominal, but not in thoracic, aorta. In summary, distinct pathophysiological response in the aortic vascular wall could be uncovered by fiber optic Raman spectroscopy based on simple parameters detecting chemical contents of lipids in PVAT.